Zobrazeno 1 - 10
of 148
pro vyhledávání: '"Nicolaas Schaap"'
Autor:
Anna Waszczuk-Gajda, Olaf Penack, Giulia Sbianchi, Linda Koster, Didier Blaise, Péter Reményi, Nigel Russell, Per Ljungman, Marek Trneny, Jiri Mayer, Simona Iacobelli, Guido Kobbe, Christof Scheid, Jane Apperley, Cyrille Touzeau, Stig Lenhoff, Esa Jantunen, Achilles Anagnostopoulos, Laura Paris, Paul Browne, Catherine Thieblemont, Nicolaas Schaap, Jorge Sierra, Ibrahim Yakoub-Agha, Laurent Garderet, Jan Styczynski, Helene Schoemans, Ivan Moiseev, Rafael F. Duarte, Zinaida Peric, Silvia Montoto, Anja van Biezen, Malgorzata Mikulska, Mahmoud Aljurf, Tapani Ruutu, Nicolaus Kröger, Curly Morris, Christian Koenecke, Stefan Schoenland, Grzegorz W. Basak
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 12, p 3541 (2022)
Background: The main goal of this post hoc analysis of the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study was to evaluate the rate of short- and long-term infectious and non-infectious complications occur
Externí odkaz:
https://doaj.org/article/dbb6995090174a7ba0e2956d0c92e9a2
Autor:
Jeannette Cany, Anniek B van der Waart, Marleen Tordoir, Gerben M Franssen, Basav N Hangalapura, Jolanda de Vries, Otto Boerman, Nicolaas Schaap, Robbert van der Voort, Jan Spanholtz, Harry Dolstra
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e64384 (2013)
Natural killer (NK) cell-based adoptive immunotherapy is an attractive adjuvant treatment option for patients with acute myeloid leukemia. Recently, we reported a clinical-grade, cytokine-based culture method for the generation of NK cells from umbil
Externí odkaz:
https://doaj.org/article/c2e6601803c9446fb2f2ad14ce819f13
Autor:
Jan Spanholtz, Frank Preijers, Marleen Tordoir, Carel Trilsbeek, Jos Paardekooper, Theo de Witte, Nicolaas Schaap, Harry Dolstra
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e20740 (2011)
Natural killer (NK) cell-based adoptive immunotherapy is a promising treatment approach for many cancers. However, development of protocols that provide large numbers of functional NK cells produced under GMP conditions are required to facilitate cli
Externí odkaz:
https://doaj.org/article/fc5b09fe7f6b45bfa59ecccf8667dd19
Autor:
Kelly Broen, Annelies Greupink-Draaisma, Rob Woestenenk, Nicolaas Schaap, Anthony G Brickner, Harry Dolstra
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e21266 (2011)
Allogeneic stem cell transplantation (SCT) is a potentially curative treatment for patients with hematologic malignancies. Its therapeutic effect is largely dependent on recognition of minor histocompatibility antigens (MiHA) by donor-derived CD8⁺
Externí odkaz:
https://doaj.org/article/c6bb57a9716143739cd1c0157512533a
Autor:
Jan Spanholtz, Marleen Tordoir, Diana Eissens, Frank Preijers, Arnold van der Meer, Irma Joosten, Nicolaas Schaap, Theo M de Witte, Harry Dolstra
Publikováno v:
PLoS ONE, Vol 5, Iss 2, p e9221 (2010)
Immunotherapy based on natural killer (NK) cell infusions is a potential adjuvant treatment for many cancers. Such therapeutic application in humans requires large numbers of functional NK cells that have been selected and expanded using clinical gra
Externí odkaz:
https://doaj.org/article/b07dc1d359f84396acf55715495275f8
Autor:
Anton F.J. de Haan, Marco R. de Groot, Nicole N.M. Blijlevens, Gerwin Huls, Andre B. Mulder, Marjan Cruijsen, Nicolaas Schaap, Joop H. Jansen, Edo Vellenga, B. Bär, Frédéric Baron, Walter J.F.M. van der Velden, Jacobien R. Hilberink
Publikováno v:
Bone Marrow Transplantation, 56, 8, pp. 1964-1970
Bone marrow transplantation, 56(8), 1964-1970. Nature Publishing Group
Bone Marrow Transplantation, 56, 1964-1970
Bone marrow transplantation, 56(8), 1964-1970. Nature Publishing Group
Bone Marrow Transplantation, 56, 1964-1970
Contains fulltext : 237746.pdf (Publisher’s version ) (Closed access) Patients with poor risk acute myeloid leukemia (AML) have a dismal outcome. We hypothesized that combining decitabine with a standard non-myeloablative (NMA) conditioning regimen
Autor:
Pavel Jindra, Depei Wu, Rama Al Hamed, Paolo Bernasconi, Manos Nikolousis, Michael Loschi, Arnon Nagler, Abdul Hamid Bazarbachi, Selim Corbacioglu, Montserrat Rovira, Virginie Gandemer, Mohamad Mohty, Matteo Pelosini, Hélène Labussière, Zinaida Peric, John A. Snowden, Wilfried Schroyens, Fabio Ciceri, Bipin N. Savani, Kazimierz Hałaburda, Nicolaas Schaap, Lucía López-Corral, Frédéric Baron, Xavier Poiré, Myriam Labopin, Enric Carreras, Blandine Guffroy, Sylvain Chantepie, Ali Bazarbachi
Publikováno v:
Bone Marrow Transplantation, 56, 917-927
Bone Marrow Transplantation, 56, 4, pp. 917-927
Bone marrow transplantation, Vol. 56, no.4, p. 917-927 (2021)
Bone marrow transplantation
Bone Marrow Transplantation, 56, 4, pp. 917-927
Bone marrow transplantation, Vol. 56, no.4, p. 917-927 (2021)
Bone marrow transplantation
Contains fulltext : 245127.pdf (Publisher’s version ) (Closed access) Allogeneic hematopoietic cell transplantation (alloHCT) is a complex, potentially fatal therapy featuring a myriad of complications. Triggering event(s) of such complications var
Autor:
Jan Styczynski, Gloria Tridello, Lidia Gil, Per Ljungman, Malgorzata Mikulska, Steffie van der Werf, Nina Simone Knelange, Diana Averbuch, Gerard Socié, Hendrik Veelken, Jean-Hugues Dalle, Mahmoud Aljurf, Alphan Kupesiz, Yves Bertrand, Abdelghani Tbakhi, Boris Afanasyev, Bruno Lioure, Hélène Labussière-Wallet, Xavier Poiré, Johan Maertens, Eefke Petersen, Patrice Chevallier, Noel Milpied, John A. Snowden, Ibrahim Yakoub-Agha, Jan Cornelissen, Nicolaas Schaap, Carlo Dufour, Regis Peffault de Latour, Arjan Lankester, Simone Cesaro
Publikováno v:
Acta Haematologica Polonica. 51:73-80
BackgroundIn patients with acute leukemia, lymphoma and chronic malignancies, donor and/or recipient Epstein-Barr virus (EBV) seropositive status increases the risk of development of chronic graft-versus-host disease (cGVHD) after allo-hematopoietic
Autor:
Marina Díaz-Beyá, Harry C. Schouten, Mauricette Michallet, Mohamad Mohty, Jordi Esteve, Jorge Sierra, Arnon Nagler, Gérard Socié, Myriam Labopin, Mahmoud Alijurf, Jakob Passweg, Nicolaas Schaap, Rainer Schwerdtfeger, Beelen Dietrich, Emmanuelle Polge, Johan Maertens, Liisa Volin
Publikováno v:
British Journal of Haematology, 189(5), 920-925. Wiley
British Journal of Haematology, 189, 5, pp. 920-925
British Journal of Haematology, 189, 920-925
British Journal of Haematology, 189, 5, pp. 920-925
British Journal of Haematology, 189, 920-925
Contains fulltext : 220562.pdf (Publisher’s version ) (Closed access) Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is a poor-risk entity, commonly associated with FLT3-ITD (internal tandem duplication). Allogeneic stem-cell tranplantation (al
Autor:
Paolo Corradini, Gerald Wulf, Christopher P. Fox, Lutz P. Müller, Nicolaus Kröger, Nadira Duraković, Michel van Gelder, Nicolaas Schaap, Jan J. Cornelissen, Peter Dreger, Mohamad Sobh, Christof Scheid, Hélène Schoemans, Paul Browne, Linda Koster, Jennifer Hoek, Mauricette Michallet, Silvia Montoto, William Krüger, Ariane Boumendil, Wolfgang Bethge, Jakob Passweg, Johannes Schetelig, Domenico Russo
Publikováno v:
Bone Marrow Transplantation, 55, 884-890
Bone Marrow Transplantation, 55(5), 884-890. Nature Publishing Group
Bone Marrow Transplantation, 55, 5, pp. 884-890
Bone Marrow Transplantation, 55(5), 884-890. Nature Publishing Group
Bone Marrow Transplantation, 55, 5, pp. 884-890
Contains fulltext : 220662.pdf (Publisher’s version ) (Closed access) The purpose of our study is to provide information on safety and efficacy of ibrutinib as salvage treatment after allo-HSCT for CLL. A total of 56 patients were included, 36 (64%